Price Prediction
Tempus AI (TEM) Stock Price Prediction: Analysts see upside, but TEM is still trading below key trend levels
Tempus AI (TEM) closed at $63.62 on November 18, 2026, then traded at $65.74 in the latest futures snapshot, while the company’s third-quarter 2026 revenue of $411.5 million helped support a fresh ...
Q3 revenue strength is the real fundamental driver
Tempus AI reported third-quarter 2026 revenue of $411.5 million on November 2, 2026, with management highlighting 32% unit growth in oncology and 33% revenue growth in Data & Applications. That matters because it shows the business is still scaling through its core precision-medicine and data platforms, which is exactly what analysts are leaning on in their target updates. Needham raised its price target to $89 from $75 and kept a Buy rating, citing the quarter’s revenue and adjusted EBITDA beat, while Reuters-quoted commentary via Investing.com pointed to more than $550 million of bookings year-to-date, including strategic wins and extensions from Merck and Bristol Myers Squibb.
Yahoo Finance shows TEM at $63.62 at the close on November 18, with a $63.86 after-hours print, and lists an average analyst target of $89.56 versus a high of $120. StockAnalysis also shows 20 analysts with a consensus Buy rating and the same $89.56 average target. That puts the stock in a clear tug-of-war: operating progress and analyst support on one side, versus a price that has not yet reclaimed the trend structure on the other.
The chart is still weak, even after the recent bounce
TEM’s latest price action is trying to stabilize, but the technical backdrop is not clean. The current price of $65.74 sits below the 7-day SMA at $67.63, the 20-day SMA at $73.11, the 50-day SMA at $71.42, the 12-day EMA at $69.90 and the 26-day EMA at $71.34. That is a short-term distribution setup, not a confirmed trend reversal.
RSI at 40.92 is neutral, but momentum is still soft: MACD is negative at -1.4396 with a flat histogram, and stochastic readings are depressed at 16.44 for %K and 13.16 for %D. Bollinger positioning also matters here: the stock is near the lower band at $62.44, with %B at 0.1545, which signals price is still hugging the lower end of its recent range rather than breaking out of it.
Key levels: what has to hold, and what has to clear
Immediate resistance is $67.18, with stronger resistance at $68.61. On the downside, immediate support is $63.05 and strong support sits at $60.35. The pivot point is $64.48, so the market is effectively balancing just above a short-term decision area.
The volume backdrop is not yet supportive of a durable reversal. The supplied volume-price structure shows only 0.07x versus the 5-day average, which points to a low-volume bounce that still needs confirmation. In other words, TEM can keep grinding higher from here, but it has to prove that buyers are willing to commit size above the first resistance band.
Derivatives are constructive, but not emphatic
Binance perpetual futures show neutral funding at 0.0000%, so there is no clear carry pressure forcing one side to pay the other. Open interest has fallen 6.43% in 24 hours to 4,688.11 contracts, with daily open interest value at $288,916, which looks more like position reduction than fresh leverage buildup.
Positioning leans mildly bullish by cohort, but not aggressively so. Binance global accounts are 59.5% long versus 40.5% short, while top-trader accounts are 63.3% long versus 36.7% short. Taker flow also tilts to the buy side at 1.1300, with buy volume 45 against sell volume 40. That combination says traders are leaning into the move, but the open-interest drop suggests conviction is not yet broad enough to call it a breakout.
What would change the setup
If TEM can reclaim the $67.18 to $68.61 resistance band on firmer volume, the stock would start to look less like a bounce and more like a trend repair attempt. If it loses $63.05, the next test is $60.35, and a break there would likely put the lower-Bollinger region into focus again.
For now, the evidence supports a measured stance: fundamentals and analyst targets are improving, but the chart still needs confirmation before the market can treat the latest rebound as more than a tactical recovery.